Cargando…
Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal
BACKGROUND: Sulphadoxine-pyrimethamine (SP) and chloroquine (CQ) have been used in treatment of falciparum and vivax malaria in Nepal. Recently, resistance to both drugs have necessitated a change towards artemisinin combination therapy (ACT) against Plasmodium falciparum in highly endemic areas. Ho...
Autores principales: | Ranjitkar, Samir, Schousboe, Mette L, Thomsen, Thomas Thyge, Adhikari, Madhav, Kapel, Christian MO, Bygbjerg, Ib C, Alifrangis, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080351/ https://www.ncbi.nlm.nih.gov/pubmed/21457533 http://dx.doi.org/10.1186/1475-2875-10-75 |
Ejemplares similares
-
Global and local genetic diversity at two microsatellite loci in Plasmodium vivax parasites from Asia, Africa and South America
por: Schousboe, Mette L, et al.
Publicado: (2014) -
Genotyping Plasmodium vivax isolates from the 2011 outbreak in Greece
por: Spanakos, Gregory, et al.
Publicado: (2013) -
THE CULTIVATION OF MALARIAL PLASMODIA (PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM) IN VITRO
por: Bass, C. C., et al.
Publicado: (1912) -
Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka
por: Schousboe, Mette L, et al.
Publicado: (2007) -
Genetic structure of Plasmodium vivax and Plasmodium falciparum in the Bannu district of Pakistan
por: Khatoon, Lubna, et al.
Publicado: (2010)